Abstract:ADVERTISEMENT RETURN TO ISSUEPREVErratumORIGINAL ARTICLEThis notice is a correctionCombined 3D-QSAR, Molecular Docking, and Molecular Dynamics Study on Piperazinyl-Glutamate-Pyridines/Pyrimidines as Potent P2Y12 Antagonists for Inhibition of Platelet AggregationMing Hao†, Yan Li*†, Yonghua Wang‡, Yulian Yan†, Shuwei Zhang†, Guohui Li§, and Ling Yang⊥View Author Information† Department of Materials Science and Chemical Engineering, Dalian University of Technology, Dalian, Liaoning, 116023, China‡ College of Life Sciences, Northwest A&F University, Yangling, Shaanxi, 712100, China§ Laboratory of Molecular Modeling and Design, State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning, 116023, China⊥ Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning, 116023, ChinaCite this: J. Chem. Inf. Model. 2011, 51, 11, 3027Publication Date (Web):November 8, 2011Publication History Published online8 November 2011Published inissue 28 November 2011https://pubs.acs.org/doi/10.1021/ci2005143https://doi.org/10.1021/ci2005143correctionACS PublicationsCopyright © 2011 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views723Altmetric-Citations1LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (611 KB) Get e-Alertsclose Get e-Alerts

Tools and DRugs BF 0801 , a novel adenine derivative , inhibits platelet activation via phosphodiesterase inhibition and P 2 Y 12 antagonism

BF0801, a novel adenine derivative, inhibits platelet activation via phosphodiesterase inhibition and P2Y12 antagonism.

BF061, a Novel Antiplatelet and Antithrombotic Agent Targeting P2Y12 Receptor and Phosphodiesterase

BF066, a novel dual target antiplatelet agent without significant bleeding.

Modulation Of Platelet Activation And Thrombus Formation Using A Pan-Pi3k Inhibitor S14161

Study on Antiplatelet Effect of a New Thiophenopyridine Platelets P2Y12 Receptor Antagonist DV-127.

Inhibition of Platelet Function by A02131-1, a Novel Inhibitor of Cgmp- Specific Phosphodiesterase, in Vitro and in Vivo

Components of Traditional Chinese Medicine Inhibit Platelet Aggregation by Blocking ADP Receptor Subtypes P2Y1 and P2Y12

Design, Synthesis and Evaluation of Novel 2-Amino-3-(naphth-2-yl)propanoic Acid Derivatives As Potent Inhibitors of Platelet Aggregation

Inhibition of Platelet Aggregation by Polyaspartoyl L-Arginine and Its Mechanism

Structure-activity relationship studies leading to the identification of (2E)-3-[l-[(2,4-dichlorophenyl)methyl]-5-fluoro-3-methyl-lH-indol-7-yl]-N-[(4,5-dichloro-2-thienyl)sulfonyl]-2-propenamide (DG-041), a potent and selective prostanoid EP3 receptor antagonist, as a novel antiplatelet agent that

Design, Synthesis and Evaluation of 1,4-Benzodioxine Derivatives As Novel Platelet Aggregation Inhibitors.

QSAR, structure-based pharmacophore modelling and biological evaluation of novel platelet ADP receptor (P2Y12) antagonist

A Pharmacodynamic Study of CN-218, a Novel Antiplatelet and Antithrombotic Agent Primarily Targeting the P2Y 12 Receptor

Advances in Research of ADP Receptors and Antagonists of Platelets

Synthesis and evaluation of carbamate-isosorbide-3-n-butylphthalide ring opening derivative trihybrids as novel platelet aggregation inhibitors

Optimization of P2Y12 Antagonist Ethyl 6-(4-((benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties

Combined 3D-QSAR, Molecular Docking, and Molecular Dynamics Study on Piperazinyl-Glutamate-Pyridines/Pyrimidines As Potent P2Y12 Antagonists for Inhibition of Platelet Aggregation

Selective Inhibition of P2Y1 and P2Y12 Receptor Signal Pathways in Platelet Aggregation in Transgenic Cell Lines and Rats by Potassium 2-(1-hydroxypentyl)-benzoate, Puerarin and Salvianolic Acid B.

Synthesis and biological evaluation of N 6 derivatives of 8-azapurine as novel antiplatelet agents

Antiplatelet Effects of Selected Xanthine-Based Adenosine A2A and A2B Receptor Antagonists Determined in Rat Blood